Novel and uncommon antimicrobial resistance genes in livestock-associated methicillin-resistant Staphylococcus aureus  by Kadlec, K. et al.
Novel and uncommon antimicrobial resistance genes in livestock-
associated methicillin-resistant Staphylococcus aureus
K. Kadlec, A. T. Feßler, T. Hauschild and S. Schwarz
Institute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Neustadt-Mariensee, Germany
Abstract
Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) isolates have been the subject of numerous studies during
recent years. The characterization of such isolates has usually also included the determination of their resistance phenotypes and associ-
ated resistance genotypes. Analysis of the resistance genes present in LA-MRSA isolates has revealed a number of genes commonly
found in S. aureus and coagulase-negative staphylococci of humans and animals. In addition, novel resistance genes and/or resistance
genes that have been rarely detected in staphylococci so far have been encountered. These include the phenicol exporter gene fexA,
the multiresistance gene cfr, the tetracycline resistance gene tet(L), the trimethoprim resistance gene dfrK, the macrolide–lincosamide–
streptogramin B resistance gene erm(T), the lincosamide–streptogramin A–pleuromutilin resistance genes vga(C) and vga(E), and the ap-
ramycin resistance gene apmA. Most of these genes were located on multiresistance plasmids in LA-MRSA. The co-localization of these
resistance genes with other resistance genes enables their co-selection and persistence. LA-MRSA can therefore act as a donor and a
recipient of antimicrobial resistance genes within the Gram-positive gene pool.
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Introduction
Since 2006, livestock-associated methicillin-resistant Staphylo-
coccus aureus (LA-MRSA) isolates have been the focus of a
considerable number of studies [1–6]. Isolates of clonal com-
plex (CC)398 have been detected most frequently. Initial anal-
yses identified such strains mainly in pigs [7,8], but they were
also found in farm personnel, veterinarians, veterinary stu-
dents, and slaughterhouse personnel [1,9]. CC398 isolates
have also been detected in other food-producing animals,
such as cattle [10–13] or poultry [14], as well as in food of
animal origin [6,15–20]. Moreover, such strains have also
been detected in horses [5,21,22], dogs [23], and black rats
[24]. Analysis of their virulence properties showed that
almost all animal-associated CC398 strains lacked the major
virulence factors of S. aureus, such as Panton–Valentine leuko-
cidin (PVL), toxic shock syndrome toxin 1, and exfoliative
toxins [1], whereas a small number of porcine CC398 isolates
carried the enterotoxin genes seb or sek + seq [25]. A closer
look at the resistance genes present in LA-MRSA CC398
revealed a wide variety of resistance genes. These include
mainly genes that are known to be commonly present in
other staphylococci of human and animal origin, such as the
b-lactamase gene cluster blaZ–blaI–blaR, the tetracycline resis-
tance genes tet(M) and tet(K), the macrolide–lincosamide–
streptogramin B (MLSB) resistance genes erm(A), erm(B),
and erm(C), the lincosamide resistance gene lnu(A), and the
genes aacA–aphD or aadD for resistance to gentamicin–
tobramycin–kanamycin or kanamycin–neomycin, respectively
[1,11,15,25–29] (Table 1). However, a number of novel
or—for staphylococci—uncommon resistance genes have
also been detected in LA-MRSA CC398 in recent years.
These include the phenicol exporter gene fexA and the
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multidrug resistance gene cfr, and also resistance genes that are
believed to have originated from other Gram-positive bacteria
and have been acquired by staphylococci, including LA-MRSA
CC398, via horizontal gene transfer. Examples of such resis-
tance genes are the tetracycline resistance gene tet(L), which is
believed to originate from Bacillus spp., and the MLSB resistance
gene erm(T), which has been reported to be present in Strepto-
coccus spp. and Lactobacillus spp. In addition, studies have also
revealed the presence of novel resistance genes that have been
described for the first time in LA-MRSA CC398 isolates, such
as the trimethoprim resistance gene dfrK, the ABC transporter
genes vga(C) and vga(E) for pleuromutilin–lincosamide–strep-
togramin A resistance, and the apramycin resistance gene
apmA (Table 1). These uncommon or novel resistance genes
form the basis of the present review.
The Phenicol Exporter Gene fexA and the
Multidrug Resistance Gene cfr
The phenicol resistance gene fexA was described in 2004 in a
bovine Staphylococcus lentus isolate. It codes for a protein of
475 amino acids that has 14 transmembrane domains [30].
The FexA protein belongs to the major facilitator superfam-
ily, and is only distantly related to other proteins involved in
the efflux of phenicols. The substrate spectrum of the FexA
TABLE 1. Summary of the resistance genes reported to occur in staphylococci and in LA-MRSA CC398
Antimicrobial resistance
phenotype Resistance mechanism
Resistance genes so far reported
to occur in staphylococci
Resistance genes so far
detected in LA-MRSA CC398a
Penicillins Enzymatic inactivation blaZ blaZ
b-lactams (penicillins, cephalosporins,
carbapenems, monobactams)b
Target site modification (alternative
penicillin binding protein)
mecA, mecALGA251 mecA
Vancomycin, teicoplanin Target site modification vanA gene cluster —
Trimethoprim Target replacement (trimethoprim-resistant
dihydrofolate reductase)
dfrA (dfrS1), dfrD, dfrG, dfrK dfrA (dfrS1), dfrD, dfrG, dfrK
Tetracyclinesc Active efflux (major facilitator superfamily) tet(K), tet(L), tet(38), tet(42)d tet(K), tet(L)
Tetracyclinese Target site protection (ribosome
protective protein)
tet(M), tet(O)d, tet(S)d, tet(W)d tet(M)
Tetracyclines Unknown tet(U)d —
Tetracyclinesf Multidrug efflux pump (MATE) mepA —
Macrolides, lincosamides,
streptogramin B
Target site modification (rRNA
methylation)
erm(A), erm(B), erm(C), erm(F)d,
erm(G)d, erm(Q)d, erm(T),
erm(Y), erm(33)
erm(A), erm(B), erm(C), erm(T)
Macrolides (14-membered) Active efflux (major facilitator
superfamily)
mef(A)d —
Macrolides (14-membered),
streptogramin B
Active efflux (ABC transporter) msr(A), msr(D)d msr(A)
Lincosamidesg Active efflux (ABC transporter) lsa(B) —
Streptogramin A (+ lincosamides,
pleuromutilins)
Active efflux (ABC transporter) vga(A) variants, vga(B), vga(C), vga(E) vga(A) variants, vga(C), vga(E)
Macrolides Enzymatic inactivation (hydrolyzation) ere(A)d, ere(B)d —
Macrolides Enzymatic inactivation (phosphorylation) mph(C) —
Lincosamides Enzymatic inactivation (nucleotidylation) lnu(A), lnu(B)d lnu(A)
Streptogramin B Enzymatic inactivation (hydrolyzation) vgb(A), vgb(B) —
Streptogramin A Enzymatic inactivation (acetylation) vat(A), vat(B), vat(C) —
Non-fluorinated phenicols Enzymatic inactivation (acetylation) catpC221, catpC223, catpC194 —
All phenicols Active efflux (major facilitator
superfamily)
fexA fexA
All phenicols, lincosamides,
oxazolidinones, pleuromutilins,
streptogramin A
Target site modification (rRNA
methylation)
cfr cfr
Gentamicin, kanamycin, tobramycin,
(amikacin)
Enzymatic inactivation (acetylation and
phosphorylation)
aacA-aphD aacA-aphD
Kanamycin, neomycin Enzymatic inactivation (adenylation) aadD aadD
Kanamycin, neomycin, amikacin Enzymatic inactivation (phosphorylation) aphA3 aphA3
Streptomycin Enzymatic inactivation (adenylation) aadE, str —
Spectinomycin Enzymatic inactivation (adenylation) spc spc
Streptothricins Enzymatic inactivation (acetylation) sat4 —
Apramycin Enzymatic inactivation (acetylation) apmA apmA
Fusidic acid Target site protection (ribosome
protective protein)
fusB, fusC —
Fusidic acid, novobiocin Active efflux (major facilitator
superfamily)
mdeA —
Mupirocin Target replacement (mupirocin-
insensitive isoleucyl-tRNA synthase)
mupA (ileS-2) mupA (ileS-2)
aThis information is mainly derived from the data presented in references [1,11,15,25,28,35,36,64,65,69,74,75,82–85,90,97].
bWith the exception of the b-lactams with anti-MRSA activity.
cTetracyclines with the exception of minocycline and glycylcyclines.
dThese genes are listed to occur in members of the genus Staphylococcus on either http://faculty.washington.edu/marilynr/ermweb4.pdf or http://faculty.washington.edu/mari-
lynr/tetweb3.pdf; however, corresponding nucleotide sequences derived from Staphylococcus isolates have not been detected during an NCBI database search.
eTetracyclines including minocycline but excluding glycylcyclines.
fIn vitro when overexpressed.
gThe gene lsa(B) confers only decreased susceptibility to lincosamides.
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protein is limited to fluorinated and non-fluorinated pheni-
cols. The fexA gene is expressed inducibly via translational
attenuation, with chloramphenicol and florfenicol acting as
inducers. Studies on the genetic environment of fexA showed
that this resistance gene is part of a non-conjugative transpo-
son, designated Tn558 [31] (Fig. 1). Except for the resistance
gene region, Tn558 shows striking structural similarities to
the erm(A)–spc-carrying transposon Tn554 [32]. Complete
or partly truncated copies of Tn558 have been identified on
plasmids or in the chromosomal DNA of various coagulase-
negative staphylococci of animal origin [33,34], and also on
plasmids in methicillin-susceptible S. aureus of sequence type
(ST)9 and methicillin-resistant S. aureus (MRSA) CC398 from
pigs [35]. Further studies also found this gene in a small
number of other unrelated MRSA CC398 isolates from pigs
[25,36] and from cattle [11].
The cfr gene was detected in 1999 on the multiresistance
plasmid pSCFS1 in a bovine Staphylococcus sciuri strain [37].
Initially, this gene was described as a chloramphenicol–florfe-
nicol resistance gene. Studies of the cfr-mediated resistance
mechanism showed that cfr codes for an rRNA methyltrans-
ferase that targets the adenine residue A2503 in 23S rRNA,
and thereby confers not only phenicol resistance, but also
clindamycin resistance [38]. Subsequent analysis showed that
cfr also mediates resistance to other antimicrobial agents that
bind to the same region of the ribosome, such as pleuromu-
tilins, streptogramin A antibiotics, and—most impor-
tantly—oxazolidinones [39,40]. Studies of the distribution of
cfr confirmed its presence mostly on plasmids, which occa-
sionally also carried fexA or other resistance genes, in vari-
ous coagulase-negative staphylococci [33,34] of food-
producing animals, but also in single isolates of porcine
MRSA ST398 and methicillin-sensitive S. aureus (MSSA) ST9
[35], a bovine MRSA ST9 isolate [41], and MSSA and MRSA
of humans [40,42–45], including a PVL-positive MRSA
USA300 strain [46] and an MRSA ST125 strain [47]. More
recent studies showed that cfr was also present in other
Gram-positive bacteria such as Bacillus spp. [48,49] and
Enterococcus faecalis [50] from pigs. Moreover, cfr has also
been found in single isolates of Gram-negative bacteria, such
as Proteus vulgaris [51] and Escherichia coli [52].
The Tetracycline Resistance Gene tet(L)
The tetracycline resistance gene tet(L) was found in the
1980s in Bacillus isolates. It is commonly located on small
plasmids, such as pBC16 from Bacillus cereus [53] (Fig. 2),
pTHT15 from Bacillus stearothermophilus [54], or pNS1 and
pNS1981 from Bacillus subtilis [55,56]. The first staphylococ-
cal tet(L)-carrying plasmid, pSTE1 from a porcine Staphylococ-
cus hyicus isolate, was identified in the early 1990s, and the
tet(L) gene region was sequenced [57]. The complete
sequence of this plasmid has been determined recently [58].
The tet(L) gene codes for a membrane-associated tetracy-
cline efflux protein of 458 amino acids, and is also expressed
inducibly via translational attenuation. Tet(L) can export tet-
racyclines, but neither minocycline nor glycylcyclines, from
FIG. 1. Comparison of the erm(A)–spc-carrying transposon Tn554 [32], the erm(A)–spc–vga(E)-carrying transposon Tn6133 [84], the dfrK-carry-
ing transposon Tn559 [67], the fexA-carrying transposon Tn558 [31], the structurally closely related erm(B)-carrying transposons Tn917 and
Tn551 [65,94], and the aacA–aphD-carrying transposon Tn4001 [65,94]. A distance scale in kb is given below each map. Insertion sequences are
shown as boxes, with the arrow inside the box indicating the transposase gene. Genes coding for transposition functions are shown as grey
arrows, and those coding for antimicrobial resistance properties as black arrows. White arrows indicate open reading frames (orfs) of unknown
function. The arrowheads show the direction of transcription.
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the bacterial cell. The tet(L) gene was detected in the 1990s
on a variety of structurally diverse plasmids in staphylococci
of animal origin [59,60]. Some of these plasmids carried addi-
tional resistance genes, such as the kanamycin–neomycin
resistance gene aadD, the MLSB resistance gene erm(B), and
the streptomycin resistance gene aadE. A survey of staphylo-
cocci of animal origin identified tet(L) in only 18 (7.9%) of
228 tetracycline-resistant isolates [61]. Among these 18 iso-
lates, three S. aureus isolates were detected, two of which
carried only tet(L), and the third of which harboured tet(L)
together with tet(M). During the analysis of LA-MRSA
CC398 isolates, tet(L) genes have been found at higher fre-
quencies, with most of the tet(L)-carrying isolates harbouring
additional tetracycline resistance genes such as tet(M) and
tet(M) + tet(K) [11,15,25,36]. Whereas the tet(M) and tet(K)
genes in LA-MRSA CC398 are commonly located in the
chromosomal DNA, the tet(L) genes are usually plasmid-
borne. The corresponding plasmids vary distinctly in size,
and may carry additional resistance genes.
The Trimethoprim Resistance Gene dfrK
Three different trimethoprim resistance genes, dfrS1 (also
known as dfrA), dfrD, and dfrG, are known to occur in staphy-
lococci, including MRSA. Among S. aureus isolates (Table 1),
the Tn4003-associated gene dfrS1 is most widespread,
whereas dfrG is most frequently detected in methicillin-resis-
tant Staphylococcus pseudintermedius [62]. Analysis of porcine
LA-MRSA CC398 isolates from the BfT-GermVet study iden-
tified three trimethoprim-resistant isolates, which, however,
were PCR-negative for the aforementioned trimethoprim
resistance genes [63]. Transfer experiments showed that tri-
methoprim and tetracycline resistance were associated with
the approximately 40-kb plasmid pKKS2187 [64]. Sequence
analysis of an approximately 7-kb segment of pKKS2187 con-
firmed the presence of a tet(L) gene and a novel trimetho-
prim resistance gene, designated dfrK [64], which codes for a
trimethoprim-resistance dihydrofolate reductase of 163
amino acids. Detailed analysis of this resistance gene region
identified a tet(L)-carrying pBC16-like plasmid bracketed by
insertion sequences of the type IS257 (Fig. 2). The observa-
tions that these IS257 copies were in the same orientation
and that typical 8-bp direct repeats were found at the bound-
aries between pBC16-homologous and IS257-homologous
sequences strongly suggested that a pBC16-like plasmid was
integrated into the pKKS2187 backbone via IS257 [64,65].
The pBC16-analogous sequence in pKKS2187, however, was
disrupted by a stretch of 1589 bp, including dfrK (Fig. 2).
Database searches did not reveal homology with known
FIG. 2. Comparative analysis of the tet(L)–dfrK region of plasmid pKKS2187 [64] and the tet(L)–dfrK–erm(T) region of plasmid pKKS25 [69] with
the completely sequenced aadD–tet(L)–dfrK–vga(C)-carrying plasmid pKKS825 [82] and the vga(C)-carrying plasmid pCPS49 [81], all from porcine
LA-MRSA CC398. The maps of the tet(L)-carrying plasmid pBC16 from Bacillus cereus [53] and the erm(T)-carrying plasmid pRW35 from Strepto-
coccus pyogenes [73] have been included for comparative reasons. The areas of >95% nucleotide sequence identity between the different plasmids
are indicated by grey shading. The arrows indicate the positions and extents of the different resistance genes; the arrowhead indicates the direc-
tion of transcription. A distance scale in kb is given below each map.
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sequences of other bacteria. Although the origin of dfrK
remains to be elucidated, analysis of the sequences flanking
this dfrK-containing segment identified imperfect 21-bp dupli-
cations that might have played a role in the integration of this
segment into a pBC16-like plasmid. Analysis of dfrK-carrying
LA-MRSA CC398 isolates from Germany identified a number
of plasmids, varying in size between 6.2 and >40 kb, all of
which carried dfrK physically linked to tet(L), although the
regions flanking these two genes varied in their structures.
However, a single MSSA CC398 isolate from the BfT-
GermVet study [66] carried dfrK not on a plasmid and not
linked to tet(L). Sequence analysis of the chromosomal dfrK
region revealed, that in this isolate, dfrK was part of the
novel Tn554-related transposon Tn559 [67]. Tn559 is
4289 bp in size and—like Tn554 [32]—integrates site-specifi-
cally in the chromosomal radC gene. Whereas Tn559 and
Tn554 have similar arrangements of the transposase genes
tnpA, tnpB, and tnpC, the Tn554-associated resistance genes
erm(A) and spc were replaced by dfrK in Tn559 (Fig. 1). Two
potential recombination sites have been identified that
explain this resistance gene replacement by recombination.
Moreover, circular forms of Tn559 were detected, and sug-
gest functional activity of this transposon [67].
Studies on the distribution of dfrK showed that it is widely
disseminated among trimethoprim-resistant LA-MRSA
CC398 isolates from pigs, cattle, and food of poultry origin.
It was found in 14 (50.0%) of 28 isolates from pigs [25], in
12 (85.7%) of 14 isolates from cattle [11], and in 22 (95.7%)
of 23 isolates from poultry meat and poultry meat products
[15]. PCR assays have been developed to differentiate
between dfrK linked to tet(L) and dfrK being part of Tn559
[11,15]. These PCR assays confirmed the presence of the
dfrK-carrying transposon Tn559 in seven of 23 trimetho-
prim-resistant LA-MRSA CC398 isolates from food of poul-
try origin [15]. Among S. aureus isolates, dfrK is not
restricted to CC398 isolates, but has also been detected in a
single MRSA ST9 isolate [15,36]. A recent study also identi-
fied dfrK and Tn559 in enterococci [68].
The MLSB Resistance Gene erm(T)
Among the various erm genes so far detected in staphylo-
cocci, the Tn554-associated gene erm(A), the Tn917/Tn551-
associated gene erm(B) (Fig. 1), and the gene erm(C), which
is often located on small plasmids, are commonly found
(Table 1). Previous studies showed that these three genes
alone or in various combinations are also present in LA-
MRSA CC398 isolates from pigs, cattle, and food of animal
origin [11,15,25,27–29,36]. The simultaneous presence of
more than one erm gene in the same isolate is not a rare
observation, and up to three different erm genes per isolate
have been detected. Each of these genes is sufficient to con-
fer clinical levels of macrolide–lincosamide resistance to the
corresponding isolate. Thus, the presence of more than one
erm gene may point towards the acquisition of these erm
genes by the respective strains at different times and/or
under different conditions. During the analysis of LA-MRSA
CC398 isolates from diseased pigs, a single macrolide–linco-
samide-resistant isolate was detected that carried none of
the aforementioned three erm genes and was also negative
for the lincosamide resistance gene lnu(A) and the macrolide
resistance genes msr(A) and mph(C) [25]. Transfer experi-
ments identified a plasmid of approximately 40 kb, desig-
nated pKKS25, which conferred resistance to MLSB
antibiotics, tetracyclines, and trimethoprim [69]. Cloning of
the resistance gene region identified the tetracycline resis-
tance gene tet(L), the trimethoprim resistance gene dfrK, and
an erm(T) gene (Fig. 2). This erm(T) gene encoded a 244-
amino acid rRNA methyltransferase that was identical to the
chromosomal Erm(T) protein of Streptococcus pasteurianus
[70], but differed by two amino acids from the plasmid-borne
Erm(T) proteins of Lactobacillus sp. [71], Lactobacillus reuteri
[72], and Streptococcus pyogenes [73]. The erm(T) gene is also
preceded by a translational attenuator which—if com-
plete—is involved in inducible erm(T) expression. In the case
of pKKS25, the erm(T)-associated translational attenuator
exhibited a 57-bp deletion that might explain the constitutive
type of erm(T) expression seen in the corresponding LA-
MRSA CC398 isolate and the pKKS25-carrying S. aureus
RN4220 transformant [69]. The erm(T) region of plasmid
pKKS25 closely resembled the respective region of plasmid
pRW35 [73] (Fig. 2). Further studies identified erm(T) in four
bovine LA-MRSA CC398 isolates [11], as well as in four LA-
MRSA CC398 isolates from turkey meat or turkey meat
products [15]. It should be noted that erm(T) has recently
been detected among MRSA CC398 isolates from humans in
Spain [74,75], and also in MSSA ST398 isolates from humans
in Belgium [76]. In the latter report, inducible expression
was shown, and sequence analysis revealed a complete trans-
lational attenuator region [76].
The Pleuromutilin–lincosamide–
streptogramin A Resistance Genes vga(C)
and vga(E)
Since the mid-1990s, efflux-mediated streptogramin A resis-
tance in staphylococci has been attributed to the genes
vga(A) and vga(B), which code for ABC transporters of 522
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or 552 amino acids [77–79]. More recently, vga(A) variants
were described that showed changes in their substrate speci-
ficity, as they also mediated resistance to lincosamides [80]
or to lincosamides and pleuromutilins [81]. The detection of
such types of resistance is hampered by the facts that: (i)
there are no clinical breakpoints applicable to staphylococci
of animal origin for streptogramin A or pleuromutilins; (ii)
streptogramin A alone is not available for therapeutic use
either in humans or in animals; and (iii) staphylococci are not
the target pathogens for pleuromutilins, such as tiamulin and
valnemulin, that are approved for veterinary use. As a conse-
quence, streptogramin A and pleuromutilins are usually not
included in routine susceptibility testing.
Among LA-MRSA CC398 isolates from pigs, vga(A) genes
or variants thereof have been detected via DNA microarray
analyses (Alere Technologies, Jena, Germany) in isolates that
showed tiamulin MICs above the tentative threshold value of
32 mg/L [25]. During the analysis of tet(L)–dfrK-carrying plas-
mids from porcine LA-MRSA CC398 isolates, the 14-kb plas-
mid pKKS825 was identified; this conferred resistance to
tetracyclines via tet(L), trimethoprim via dfrK, kanamycin–
neomycin via aadD, lincosamides, pleuromutilins, and the
streptogramin A compound virginiamycin M1 [82] (Fig. 2).
Analysis of the sequence of this plasmid led to the detection
of a novel ABC transporter gene; the deduced 522 amino
acid sequence of the corresponding protein showed only
62–65% amino acid identity with the staphylococcal Vga(A)
proteins, and 39% identity with the Vga(B) proteins. This
novel ABC transporter gene was designated vga(C). PCR
screening identified the vga(C) gene in another three porcine
isolates and a single bovine LA-MRSA CC398 isolate [11].
Moreover, it was also found in five LA-MRSA CC398 isolates
from food of poultry origin [15].
During the European Community baseline study, LA-MRSA
CC398 isolates were detected in Portugal that displayed an
unusual resistance phenotype, namely resistance to lincosa-
mides, but susceptibility to macrolides. Further analysis of such
isolates showed that they harboured small plasmids of 5.7 kb
or 5.3 kb that carried vga(A) (pCPS32) or vga(C) (pCPS49),
respectively, as their sole resistance gene [83]. The vga(A)-car-
rying plasmid type was structurally closely related to plasmid
pVGA from a human clinical isolate [81]. This observation sug-
gested that an exchange of this plasmid type between humans
and pigs has already occurred. In contrast, the structural simi-
larity between plasmids pCPS49 and pKKS825 was limited
exclusively to the vga(C) gene region (Fig. 2).
In 2011, another novel vga gene, vga(E), was detected in a
porcine LA-MRSA ST398 isolate from Switzerland [84]. This
gene codes for an ABC transporter of 524 amino acids, which
also confers resistance to pleuromutilins, lincosamides, and
streptogramin A antibiotics. The vga(E) gene was located on
the novel 11 475-bp transposon Tn6133, which represented
a Tn554 variant with a stably integrated 4787-bp DNA
sequence that included vga(E) (Fig. 1). Like Tn554, Tn6133
integrates preferentially into the chromosomal radC gene of
S. aureus. PCR screening identified vga(E) and Tn6133 in LA-
MRSA CC398 isolates from cattle (n = 2), turkey (n = 1) and
food of poultry origin (n = 6) from Germany [85].
The Apramycin Resistance Gene apmA
The aminocyclitol apramycin is a broad-spectrum antibiotic
that is approved exclusively for use in veterinary medicine. It
is particularly active against Gram-negative bacteria, and is
commonly used to treat E. coli infections (colibacillosis) in
pigs, but it has also been approved for use in cattle, sheep,
poultry, and rabbits. In Gram-negative bacteria, resistance to
apramycin is mediated by aac(3)-IV, which is located most
commonly on plasmids and confers cross-resistance to genta-
micin [86–89]. Up to 2011, no information about the genetic
basis of apramycin resistance in staphylococci was available.
During three survey studies on LA-MRSA CC398, four of
54 isolates from diseased swine [25], two of 16 isolates from
dairy cattle suffering from mastitis [11] and one of 28 iso-
lates from poultry meat/poultry meat products [15] exhibited
apramycin MIC values of 32–128 mg/L. These MICs were dis-
tinctly higher than the mode MICs (2–4 mg/L) of the respec-
tive test populations. Plasmid transfer experiments identified
40 kb multiresistance plasmids, which showed similar
EcoRI, HindIII, BglII and PvuI restriction patterns. These plas-
mids conferred not only tetracycline resistance via tet(L), tri-
methoprim resistance via dfrK, kanamycin–neomycin
resistance via aadD, and MLSB resistance via erm(B), but also
high apramycin MICs via a hitherto unknown resistance gene
[90]. One such plasmid, designated pAFS11, was chosen for
further characterization, and sequence analysis of an 11.3-kb
EcoRI fragment revealed the presence of the novel apramycin
resistance gene apmA immediately downstream of erm(B).
The apmA gene codes for a 274-amino acid acetyltransferase
protein that is only distantly related to other acetyltransfe-
rases. It should be noted that apmA-carrying strains were
classified by their MICs as being borderline susceptible to
gentamicin. PCR screening and hybridization experiments
identified apmA in the remaining six isolates.
Susceptibility testing of the aforementioned vga-carrying
LA-MRSA CC398 isolates from the European Community
baseline study identified a single isolate with a high apramycin
MIC. Transformation experiments and PCR analysis identified
the 4.1-kb apmA-carrying plasmid pKKS49. Homology
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between pKKS49 and the distinctly larger plasmid pAFS11
was limited to apmA and 72 bp in the apmA upstream region
and 64 bp in the apmA downstream region [91].
The Role of Mobile Genetic Elements in
the Acquisition of Antimicrobial Resistance
Genes by LA-MRSA CC398
Efficient horizontal gene transfer requires: (i) resistance
genes to be located on mobile genetic elements; (ii) close
contact between the partners, which is usually provided in
the polymicrobial environments on the skin and on the
mucosal surfaces; and (iii) a selective pressure, such as
imposed by the use of antimicrobial agents. Studies on the
mobility and the localization of resistance genes in LA-MRSA
CC398 isolates showed that many resistance genes were
located on mobile genetic elements such as plasmids or
transposons. As a colonizer of the skin and the mucosal sur-
faces of the anterior nares, LA-MRSA CC398 is in close con-
tact with various other bacteria present in the respective
hosts. As LA-MRSA CC398 isolates have been encountered
not only in different hosts (e.g. humans, pigs, cattle, horses,
poultry, dogs, and rats), but also in various geographical
regions (e.g. Europe, North America, and Asia), such isolates
may be subject to variable selective pressures based on pref-
erences in the application of antimicrobial agents in humans
and different animal species in different countries and parts
of the world. Moreover, LA-MRSA CC398 may also be sub-
ject to selective pressures by antimicrobial agents that are
not primarily used to control staphylococcal infections,
and—under such a selective pressure—may develop or
acquire corresponding resistance genes. It is important to
understand that, although the application of an antimicrobial
agent is aimed at combating the target pathogens, the com-
mensal or temporarily colonizing microflora is also put under
selective pressure by the antimicrobial agent. In this regard,
all phenicol-resistant LA-MRSA CC398 isolates seen so far in
pigs and cattle carry fexA or cfr [11,25,35,41] but none of
the chloramphenicol acetyltransferase genes, catpC221,
catpC223, catpC194, which are widespread in staphylococci
(Table 1). This may be because florfenicol is commonly used
in pigs and cattle to control respiratory tract infections, and
the chloramphenicol acetyltransferases encoded by the afore-
mentioned cat genes do not confer florfenicol resistance
[92]. Another example is the occurrence of apmA, which has
probably been selected by apramycin use in the respective
animals for the control of enterobacterial infections.
Analysis of the staphylococcal resistome has shown that
staphylococci do not live in genetic isolation, but exchange
genetic material with various other Gram-positive and—in
selected cases—also Gram-negative bacteria [92–96]. In this
regard, LA-MRSA CC398 does not represent an exception.
Plasmids and transposons play a key role in the horizontal
dissemination of antimicrobial resistance genes across species
and genus boundaries, with LA-MRSA CC398 being capable
of acting both as a donor and as a recipient. However, plas-
mids from non-staphylococcal host bacteria, such as the
small erm(T)-carrying plasmids from streptococci or lactoba-
cilli, may not be able to replicate in LA-MRSA CC398.
Recombination or co-integrate formation of these foreign
plasmids with plasmids indigenous to LA-MRSA CC398
allows maintenance in the new host and use of the newly
acquired resistance genes [65]. Moreover, such recombina-
tion events also play a role in the accumulation of resistance
genes and the formation of novel multiresistance plasmids or
transposons. One example is plasmid pKKS825 [82], which
carries: (i) four different resistance genes (tet(L), dfrK, aadD,
and vga(C)), and thereby confers resistance to members of
six classes of antimicrobial agent (tetracyclines, trimethoprim,
kanamycin–neomycin, streptogramin A antibiotics, lincosa-
mides, and pleuromutilins); (ii) three different rep genes for
potential replication in different bacterial hosts; and (iii) two
different pre/mob genes for plasmid mobilization and plasmid
recombination (Fig. 2). Another example is the newly identi-
fied transposon Tn6133, which harbours three different
resistance genes (erm(A), spc, and vga(E)), and thereby medi-
ates resistance to six classes of antimicrobial agent (macro-
lides, lincosamides, streptogramin B antibiotics,
spectinomycin, streptogramin A antibiotics, and pleuromuti-
lins) [84] (Fig. 1). However, recombinations may also occur
between plasmids and transposons, as shown in the case of
transposon Tn559, where recombination events resulted in
the replacement of the Tn554-associated resistance genes
erm(A) and spc by the plasmid-borne gene dfrK [67].
Physical linkage of resistance genes, as in the case of
tet(L)–dfrK, or co-localization of different resistance genes on
the same mobile genetic element enable not only the co-
selection, but also the persistence, of different resistance
genes under the selective pressure imposed by the use of a
single antimicrobial agent. Under such conditions, it cannot
be expected that the banning or the largely restricted use of
a certain antimicrobial agent will necessarily result in a rapid
and distinct decrease in the corresponding resistance rates.
Conclusion and Perspective
Recent studies analysing 80 genomes of LA-MRSA CC398
isolates from all over the world have suggested that LA-
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MRSA CC398 started as an MSSA CC398 in humans, which
changed hosts and acquired new resistance properties (such
as methicillin resistance and tetracycline resistance) in the
new host [97]. The analysis of further resistance genes and
their location in LA-MRSA CC398 provides insights into the
gene acquisition capacities of these isolates, their role as
recipients and donors of resistance genes, and possible part-
ners for resistance gene exchange processes beyond the
genus Staphylococcus. In addition, the knowledge about co-
localization, organization in clusters and physical linkage of
antimicrobial resistance genes furthers our understanding of
the co-selection and persistence of resistance genes even in
the absence of a direct selective pressure.
It is difficult to foresee which novel resistance genes will be
acquired by LA-MRSA CC398 in the future. However, the
examples shown in this review underline that LA-MRSA
CC398 isolates are able to acquire and stably maintain resis-
tance genes from other bacteria. Continuous monitoring of
the resistance properties of LA-MRSA CC398 isolates is war-
ranted to detect the occurrence and dissemination of novel
resistance traits. Such monitoring studies should ideally also
include the detection of the corresponding resistance genes
and their association with mobile genetic elements. This infor-
mation might be of particular relevance for the assessment of
the emergence of resistance to ‘last-resort’ antimicrobial
agents, such as oxazolidinones, in LA-MRSA CC398. As the
corresponding resistance gene, cfr, has already arrived in a sin-
gle porcine LA-MRSA CC398 isolate [35] and bovine MRSA
ST9 [41] isolates in different parts of the world, the future will
show whether—and, if so, how fast—it will spread [98].
Because LA-MRSA CC398 isolates are able to accept foreign
genetic material, as shown in the case of antimicrobial resis-
tance genes, they may also acquire virulence genes. The first
PVL-positive MRSA CC398 isolates were identified among
hospitalized patients in China [99], in two unrelated, adopted
children from China [100,101], and from a human wound/
abscess in a patient in The Netherlands [102]. Thus, the
molecular characterization of a rapidly evolving zoonotic path-
ogen, such as LA-MRSA CC398, should also include virulence
genes that pose a hazard to human and animal health [1].
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